Treatment with GLP-1 drugs must not replace obesity prevention in low and middle income countries

Research output: Contribution to journal › Editorial › Other › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{f48b7880d28e475291161808e1be27e9,

title = "Treatment with GLP-1 drugs must not replace obesity prevention in low and middle income countries",

author = "Kent Buse and Angela Carriedo and Simon Barquera",

year = "2026",

month = mar,

day = "2",

doi = "10.1136/bmj.s407",

language = "English",

volume = "392",

journal = "BMJ",

issn = "0959-535X",

publisher = "BMJ",

}

TY - JOUR

T1 - Treatment with GLP-1 drugs must not replace obesity prevention in low and middle income countries

AU - Buse, Kent

AU - Carriedo, Angela

AU - Barquera, Simon

PY - 2026/3/2

Y1 - 2026/3/2

UR - https://www.scopus.com/pages/publications/105031763148

U2 - 10.1136/bmj.s407

DO - 10.1136/bmj.s407

M3 - Editorial

C2 - 41771658

AN - SCOPUS:105031763148

SN - 0959-535X

VL - 392

JO - BMJ

JF - BMJ

M1 - s407

ER -